Abstract:The World Health Organization designates lidocaine as an essential medicine in healthcare, greatly increasing the probability of human exposure. Its use has been associated with ROS generation and neurotoxicity. Physiological and metabolomic alterations, and genetics leading to the clinically observed adverse effects have not been temporally characterized. To study alterations that may lead to these undesirable effects, Saccharomyces cerevisiae grown on aerobic carbon sources to stationary phase was assessed over 6h. Exposure of an LC50 dose of lidocaine, increased mitochondrial depolarization and ROS/RNS generation assessed using JC-1, ROS/RNS specific probes, and FACS. Intracellular calcium also increased, assessed by ICP-MS. Measurement of the relative ATP and ADP concentrations indicates an initial 3-fold depletion of ATP suggesting an alteration in the ATP:ADP ratio. At the 6h time point the lidocaine exposed population contained ATP concentrations roughly 85% that of the negative control suggesting the surviving population adapted its metabolic pathways to, at least partially restore cellular bioenergetics. Metabolite analysis indicates an increase of intermediates in the pentose phosphate pathway, the preparatory phase of glycolysis, and NADPH. Oxidative stress produced by lidocaine exposure targets aconitase decreasing its activity with an observed decrease in isocitrate and an increase citrate. Similarly, increases in α-ketoglutarate, malate, and oxaloacetate imply activation of anaplerotic reactions. Antioxidant molecule glutathione and its precursor amino acids, cysteine and glutamate were greatly increased at later time points. Phosphatidylserine externalization suggestive of early phase apoptosis was also observed. Genetic studies using metacaspase null strains showed resistance to lidocaine induced cell death. These data suggest lidocaine induces perpetual mitochondrial depolarization, ROS/RNS generation along with increased glutathione to combat the oxidative cellular environment, glycolytic to PPP cycling of carbon generating NADPH, obstruction of carbon flow through the TCA cycle, decreased ATP generation, and metacaspase dependent apoptotic cell death.

Ribonucleic Acid Sequencing Reveals the Upregulation and Resolution of Inflammation and Extracellular Matrix Remodeling in Lidocaine-Treated Human Acute Monocytic Leukemia Cell Line THP-1

Microrna 218 Modulates Pkc/Akt Pathway To Protect Lidocaine-Induced Neurotoxicity In Ganglia In Vitro

Long Noncoding RNA LINC01347 Modulated Lidocaine-Induced Cytotoxicity in SH-SY5Y Cells by Interacting with hsa-miR-145-5p

Amide-linked local anesthetics induce apoptosis in human non-small cell lung cancer.

Lidocaine hydrochloride increased apoptosis of SH-SY 5 Y cells through p 38 MARK mediated DNA methylation

Lidocaine Attenuates Proinflammatory Cytokine Production Induced By Extracellular Adenosine Triphosphate In Cultured Rat Microglia

Lidocaine inhibits osteogenic differentiation of human dental pulp stem cells in vitro

Analysis of the Long Non-Coding RNA and Mrna Expression Profiles Associated with Lidocaine-Induced Neurotoxicity in the Spinal Cord of a Rat Model.

Anticancer Role of Lidocaine in Oral Squamous Cell Carcinoma Through IGF2BP2-mediated CAV1 Stability

The Protective Effect of Lidocaine on Lipopolysaccharide-Induced Acute Lung Injury in Rats Through NF-κB and P38 MAPK Signaling Pathway and Excessive Inflammatory Responses.

Lidocaine reduces pain behaviors by inhibiting the expression of Nav1.7 and Nav1.8 and diminishing sympathetic sprouting in SNI rats

Treatment of lidocaine on subacute thyroiditis via restraining inflammatory factor expression and inhibiting pyroptosis pathway.

Lidocaine inhibits proliferation and metastasis of lung cancer cell via regulation of miR-539/EGFR axis

Human Bone Marrow Mesenchymal Stem Cells-derived Exosomal miRNA-21-5p Inhibits Lidocaine-induced Apoptosis in SH-SY5Y Neuroblastoma Cells

Effect of TRPV1 Combined with Lidocaine on Cell State and Apoptosis of U87-MG Glioma Cell Lines.

Polymeric Nanocapsules Loaded with Lidocaine: A Promising Formulation for Topical Dental Anesthesia

Lidocaine Induces Apoptosis And Suppresses Tumor Growth In Human Hepatocellular Carcinoma Cells In Vitro And In A Xenograft Model In Vivo

Lidocaine relieves murine allergic rhinitis by regulating the NF-κB and p38 MAPK pathways

Local Anesthetic Lidocaine and Cancer: Insight Into Tumor Progression and Recurrence

Effects of Lidocaine-Derived Organic Compounds on Eosinophil Activation and Survival

Oxidative stress, metabolomics profiling, and mechanism of local anesthetic induced cell death in yeast